109 related articles for article (PubMed ID: 20357516)
1. Individual life expectancy estimation using validated prognostic scores for patients with cancer of unknown primary.
Ferté C; Penel N; Bonneterre J; Adenis A
Oncology; 2010; 78(2):87-93. PubMed ID: 20357516
[TBL] [Abstract][Full Text] [Related]
2. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
Trivanović D; Petkovic M; Stimac D
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
[TBL] [Abstract][Full Text] [Related]
3. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
Seve P; Ray-Coquard I; Trillet-Lenoir V; Sawyer M; Hanson J; Broussolle C; Negrier S; Dumontet C; Mackey JR
Cancer; 2006 Dec; 107(11):2698-705. PubMed ID: 17063500
[TBL] [Abstract][Full Text] [Related]
4. [Predictive value of three surgical scoring systems for estimation of life expectancy in patients with extradural spinal metastasis].
Liang TZ; Wan Y; Long GH; Zou XN; Peng XS; Zheng ZM
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):875-9. PubMed ID: 21223698
[TBL] [Abstract][Full Text] [Related]
5. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
[TBL] [Abstract][Full Text] [Related]
6. [P53-status in primary ovarian carcinomas, ovarian metastases of neoplasms in other sites and benign ovarian tumors: predictive value in comparison to histopathological parameters].
Casper F; Weikel W; Schaffrath M; Kuner RP; Hoffmann G; Pollow B; Pollow K
Zentralbl Gynakol; 2000; 122(3):153-9. PubMed ID: 10756599
[TBL] [Abstract][Full Text] [Related]
7. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
Walz J; Gallina A; Perrotte P; Jeldres C; Trinh QD; Hutterer GC; Traumann M; Ramirez A; Shariat SF; McCormack M; Perreault JP; Bénard F; Valiquette L; Saad F; Karakiewicz PI
BJU Int; 2007 Dec; 100(6):1254-8. PubMed ID: 17979925
[TBL] [Abstract][Full Text] [Related]
8. Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale.
Chuang RB; Hu WY; Chiu TY; Chen CY
J Pain Symptom Manage; 2004 Aug; 28(2):115-22. PubMed ID: 15276192
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
10. Single-center management of 136 patients with cancer of unknown primary site (CUP syndrome) over a period of 10 years.
Thöm I; Rogers C; Andritzky B; Witzel I; Schuch G; Hossfeld DK; Bokemeyer C; Laack E
Onkologie; 2009 Dec; 32(12):741-6. PubMed ID: 20016235
[TBL] [Abstract][Full Text] [Related]
11. [The predictive value of the Tokuhashi revised scoring system for the survival time of patients with spinal metastases].
Zeng JC; Song YM; Liu H; Gong Q; Li T; Liu LM; Hu YZ; Pei FX; Rao SC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):488-91. PubMed ID: 17593839
[TBL] [Abstract][Full Text] [Related]
12. The Chinese classification system compared with TNM staging in prognosis of patients with primary hepatic carcinoma after resection.
Sheng JM; Zhao WH; Wu FS; Ma ZM; Feng YZ; Zhou XR; Teng LS
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):561-4. PubMed ID: 16286262
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institution.
Fleckenstein K; Hof H; Lohr F; Wenz F; Wannenmacher M
Strahlenther Onkol; 2004 May; 180(5):268-73. PubMed ID: 15127156
[TBL] [Abstract][Full Text] [Related]
14. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care.
Nathan SS; Healey JH; Mellano D; Hoang B; Lewis I; Morris CD; Athanasian EA; Boland PJ
J Clin Oncol; 2005 Sep; 23(25):6072-82. PubMed ID: 16135474
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
[TBL] [Abstract][Full Text] [Related]
16. Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation.
Minagawa M; Yamamoto J; Kosuge T; Matsuyama Y; Miyagawa S; Makuuchi M
Arch Surg; 2007 Mar; 142(3):269-76; discussion 277. PubMed ID: 17372052
[TBL] [Abstract][Full Text] [Related]
17. [Hepatic metastasis of unknown primary site].
Mousseau M; Schaerer R; Lutz JM; Ménégoz F; Faure H; Swiercz P
Bull Cancer; 1991; 78(8):725-36. PubMed ID: 1932839
[TBL] [Abstract][Full Text] [Related]
18. Prediction of survival time in advanced cancer: a prognostic scale for Chinese patients.
Lingjun Z; Jing C; Jian L; Wee B; Jijun Z
J Pain Symptom Manage; 2009 Oct; 38(4):578-86. PubMed ID: 19608378
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer.
Glare PA; Eychmueller S; McMahon P
J Clin Oncol; 2004 Dec; 22(23):4823-8. PubMed ID: 15570085
[TBL] [Abstract][Full Text] [Related]
20. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.
Chau I; Norman AR; Cunningham D; Waters JS; Oates J; Ross PJ
J Clin Oncol; 2004 Jun; 22(12):2395-403. PubMed ID: 15197201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
